The rupiah rose 60 points, or 0.4 percent, to open at Rp14,820 per dollar from Rp14,880 per dollar earlier.
"The money market still looks at the positive sentiments arising from the large acquisition of US companies, the resumed clinical trials of the AstraZeneca COVID-19 vaccine, and the rising US Stock Index overnight," Chief of Research and Education of Monex Investindo Futures Ariston Tjendra stated on Tuesday.
Before The Fed’s announcement of the results of its meeting early on Thursday, the market expects the US central bank to issue a dovish or pessimistic statement on the US economic recovery and maintain the loose policy for a longer period of time.
"The expectation will potentially lend a positive sentiment to risk assets and exert pressure on the US dollar," he pointed out.
Tjendra has projected the rupiah to strengthen within the range of Rp14,750 to Rp14,950 per dollar on Tuesday.
The rupiah rose 10 points, or 0.07 percent, to close at Rp14,880 on Monday against Rp14,890 earlier.
Related news: Rupiah weakens against dollar before weekend as PSBB returns
Related news: Rupiah to likely record another correction over PSBB re-imposition
Related news: Rupiah expected to reel under pressure over tense US-China ties